(Q46783280)

25 December 2017

title

Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus). (English)

1 reference

25 December 2017

1 reference

Cercopithecus aethiops

object named as

Cercopithecus aethiops

1 reference

inferred from title

parkinsonian syndrome

1 reference

Taylor JR

1

1 reference

25 December 2017

Elsworth JD

2

1 reference

25 December 2017

Roth RH

3

1 reference

25 December 2017

Sladek JR Jr

4

1 reference

25 December 2017

Redmond DE Jr

5

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

25 December 2017

number of pages

11

1 reference

inferred from page(s)

published in

Neuroscience

1 reference

25 December 2017

volume

81

1 reference

25 December 2017

issue

3

1 reference

25 December 2017

page(s)

745-755

1 reference

25 December 2017

Behavioural analysis of unilateral monoamine depletion in the marmoset

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Biochemical and behavioral correction of MPTP Parkinson-like syndrome by fetal cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism. Histochemical and behavioral studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

MPTP primate model of Parkinson's disease: a mechanographic and electromyographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

A method for quantitating motor deficits in a nonhuman primate following MPTP-induced hemiparkinsonism and co-grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Differential responsiveness to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in sub-regions of the primate substantia nigra and striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: biochemical changes in striatal regions

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

MPTP reduces dopamine and norepinephrine concentrations in the supplementary motor area and cingulate cortex of the primate

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Functional recovery in parkinsonian monkeys treated with GDNF

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Intracarotid 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration: biochemical and behavioral observations in a primate model of hemiparkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Interobserver reliability between neurologists in training of Parkinson's disease rating scales. A multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Scales for rating motor impairment in Parkinson's disease: studies of reliability and convergent validity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

The reliability of clinical assessment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Alterations in motor behaviour produced by the isomers of 3-PPP in the MPTP-treated marmoset

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Transient depletion of nucleus accumbens dopamine content may contribute to initial akinesia induced by MPTP in common marmosets

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Repeated Exposure to MPTP Does Not Produce a Permanent Movement Disorder in Cats Recovered from MPTP-induced Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Responses of striatal neurons to peripheral sensory stimulation in symptomatic MPTP-exposed cats.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Deficits in operant behaviour in monkeys treated with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Production of a Parkinson-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior, histology, and biochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Deficits in behavioral initiation and execution processes in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Developing a stable bilateral model of parkinsonism in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Intellectual changes in patients with MPTP-induced parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Sham surgery does not ameliorate MPTP-induced behavioral deficits in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

Cognitive and motor deficits in the performance of an object retrieval task with a barrier-detour in monkeys (Cercopithecus aethiops sabaeus) treated with MPTP: long-term performance and effect of transparency of the barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900214-5

7 January 2021

10.1016/S0306-4522(97)00214-5

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017